Ameriprise Financial Inc Agios Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 73,402 shares of AGIO stock, worth $2.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,402

Previous 71,889 2.1%

Holding current value

$2.41 Million

Previous $3.1 Million 5.23%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $62,320 - $75,226	1,513 Added 2.1%	73,402 $3.26 Million
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $55,568 - $98,490	2,017 Added 2.89%	71,889 $3.1 Million
Q1 2024 May 15, 2024	SELL	$21.32 - $34.81 $65,111 - $106,309	-3,054 Reduced 4.19%	69,872 $2.04 Million
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $3.76 Million - $4.62 Million	-188,180 Reduced 72.07%	72,926 $1.62 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $1.56 Million - $1.81 Million	-64,115 Reduced 19.71%	261,106 $6.46 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $417,059 - $569,409	19,507 Added 6.38%	325,221 $9.21 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $1.47 Million - $2.09 Million	67,705 Added 28.45%	305,714 $7.02 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $1.93 Million - $2.46 Million	77,932 Added 48.68%	238,009 $6.68 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $3.12 Million - $5.47 Million	160,077 New	160,077 $4.53 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $1.63 Million - $2.75 Million	-55,185 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $1.82 Million - $2.53 Million	-43,486 Reduced 44.07%	55,185 $2.55 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $2.3 Million - $2.7 Million	44,146 Added 80.96%	98,671 $5.44 Million
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $354,414 - $460,747	8,013 Added 17.23%	54,525 $2.82 Million
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $661,443 - $926,937	-19,917 Reduced 29.98%	46,512 $2.02 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $2.1 Million - $3.47 Million	62,087 Added 1429.92%	66,429 $2.33 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $4.07 Million - $6.31 Million	-118,068 Reduced 96.45%	4,342 $232,000
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $30.4 Million - $51.9 Million	-964,438 Reduced 88.74%	122,410 $4.34 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $6.31 Million - $10.6 Million	-209,776 Reduced 16.18%	1,086,848 $51.9 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $6.44 Million - $9.85 Million	198,622 Added 18.09%	1,296,624 $42 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $21.4 Million - $31.6 Million	464,123 Added 73.22%	1,098,002 $54.8 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $629,379 - $927,485	-13,706 Reduced 2.12%	633,879 $42.7 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $6.58 Million - $11.8 Million	153,944 Added 31.19%	647,585 $29.9 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $12.3 Million - $15.8 Million	172,091 Added 53.52%	493,641 $38.1 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $13 Million - $17.6 Million	-176,871 Reduced 35.49%	321,550 $27.1 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $26.6 Million - $38.4 Million	443,934 Added 814.75%	498,421 $40.8 Million
Q4 2017 Feb 12, 2018	SELL	$52.12 - $72.33 $157,246 - $218,219	-3,017 Reduced 5.25%	54,487 $3.12 Million
Q3 2017 Nov 07, 2017	BUY	$54.89 - $67.12 $3.16 Million - $3.86 Million	57,504	57,504 $3.84 Million

Others Institutions Holding AGIO

# of Institutions

240

Shares Held

57.9M

Call Options Held

407K

Put Options Held

473K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.8B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Agios Pharmaceuticals, Inc. Transaction History